Veritable, L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Veritable, L.P.

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$700.03 - $830.35 $72,103 - $85,526	-103 Reduced 4.52%	2,178 $1.56 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $133,376 - $162,086	196 Added 9.4%	2,281 $1.87 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $39,529 - $42,917	56 Added 2.76%	2,085 $1.5 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $90,687 - $114,442	158 Added 8.44%	2,029 $1.4 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $21,934 - $29,553	-40 Reduced 2.09%	1,871 $1.11 Million
Q1 2022 May 11, 2022	BUY	$595.12 - $698.43 $30,351 - $35,619	51 Added 2.74%	1,911 $1.34 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $79,348 - $97,961	146 Added 8.52%	1,860 $1.18 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $2,296 - $2,723	-4 Reduced 0.23%	1,714 $1.04 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $25,058 - $29,602	53 Added 3.18%	1,718 $960,000
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $25,463 - $31,247	-57 Reduced 3.31%	1,665 $788,000
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $7,652 - $9,727	16 Added 0.94%	1,722 $832,000
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $17,432 - $21,062	-32 Reduced 1.84%	1,706 $955,000
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $39,958 - $52,157	-81 Reduced 4.45%	1,738 $1.08 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $69,253 - $101,852	206 Added 12.77%	1,819 $888,000
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $15,899 - $21,837	58 Added 3.73%	1,613 $606,000
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $546 - $636	-2 Reduced 0.13%	1,555 $431,000
Q2 2019 Aug 12, 2019	SELL	$299.6 - $414.82 $150,998 - $209,069	-504 Reduced 24.45%	1,557 $487,000
Q1 2019 May 15, 2019	SELL	$372.08 - $439.57 $77,392 - $91,430	-208 Reduced 9.17%	2,061 $846,000
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $94,701 - $113,657	282 Added 14.19%	2,269 $847,000
Q3 2018 Nov 14, 2018	BUY	$351.14 - $408.51 $1,053 - $1,225	3 Added 0.15%	1,987 $803,000
Q2 2018 Aug 13, 2018	SELL	$284.6 - $344.99 $146,569 - $177,669	-515 Reduced 20.61%	1,984 $684,000
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $76,428 - $95,294	242 Added 10.72%	2,499 $861,000
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $157,797 - $206,778	-440 Reduced 16.31%	2,257 $849,000
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $1.16 Million - $1.36 Million	2,697	2,697 $1.21 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.

Account